IN VITRO SUSCEPTIBILITY STUDIES WITH JOSAMYCIN AND ERYTHROMYCINSTRAUSBAUGH LJ; DILWORTH JA; GWALTNEY JM JR et al.1976; ANTIMICROB. AGENTS CHEMOTHERAPY; U.S.A.; DA. 1976; VOL. 9; NO 3; PP. 546-548; BIBL. 3 REF.Article

STUDIES ON A NEW ALKALINE DEGRADATION PRODUCT OF JOSAMYCIN.OSONO T; MORIYAMA K; MURAKAMI M et al.1974; J. ANTIBIOT.; JAP.; DA. 1974; VOL. 27; NO 5; PP. 366-369; BIBL. 7 REF.Article

INFLUENCE OF FOOD AND HEPATOBILIARY DISEASE ON THE EXCRETION OF JOSAMYCINBERGAN T; TOLAS P; OEYDVIN B et al.1972; PHARMACOLOGY; SWITZ.; DA. 1972; VOL. 8; NO 4-6; PP. 336-343; BIBL. 3 REF.Serial Issue

IN VITRO SUSCEPTIBILITIES OF ANAEROBIC BACTERIA TO JOSAMYCINLONG SS; MUELLER S; SWENSON RM et al.1976; ANTIMICROB. AGENTS CHEMOTHERAPY; U.S.A.; DA. 1976; VOL. 9; NO 5; PP. 859-860; BIBL. 7 REF.Article

Kinetic spectrophotometric determination of the macrolide antibiotic josamycin in formulationsAL-MAJED, Abdulrahman A; BELAL, Fathalla; IBRAHIM, Kamal E. E et al.Journal of AOAC International. 2003, Vol 86, Num 3, pp 484-489, issn 1060-3271, 6 p.Article

Characterization of impurities in josamycin using dual liquid chromatography combined with mass spectrometryVAN DEN BOSSCHE, Larissa; DAIDONE, Frederick; VAN SCHEPDAEL, Ann et al.Journal of pharmaceutical and biomedical analysis. 2013, Vol 73, pp 66-76, issn 0731-7085, 11 p.Conference Paper

SUSCEPTIBILITY OF NEISSERIA MENINGITIDIS TO JOSAMYCIN.FANNING WL; GUMP DW; HORTON ED et al.1976; CURR. THERAPEUT. RES.; U.S.A.; DA. 1976; VOL. 20; NO 1; PP. 99-102; BIBL. 14 REF.Article

LA JOSAMYCINE EN PNEUMOLOGIEKALB JC; GUERIN JC; CHAVAILLON JM et al.1981; LYON MEDITERR. MED.; ISSN 0399-032X; FRA; DA. 1981; VOL. 17; NO 17; PP. 5098-5100; BIBL. 2 REF.Article

PLACE DE LA JOSAMYCINE DANS LE TRAITEMENT DES OTITES AIGUES. A PROPOS DE 123 OBSERVATIONSSAUVAGE JP; PESTRE ALEXANDRE M; CABANETTES JP et al.1982; CAH. OTO-RHINO-LARYNGOL. CHIR. CERV. FAC. AUDIOPHONOL.; ISSN 0395-3971; FRA; DA. 1982; VOL. 17; NO 2; PP. 167-170Article

Preparation of floating microspheres for fish farmingNEPAL, Pushp R; CHUN, Myung-Kwan; CHOI, Hoo-Kyun et al.International journal of pharmaceutics. 2007, Vol 341, Num 1-2, pp 85-90, issn 0378-5173, 6 p.Article

MACROLIDE ET THEOPHYLLINE: ABSENCE D'INTERACTION JOSAMYCINE-THEOPHYLLINERUFF F; SANTAIS MC; CHASTAGNOL D et al.1981; NOUV. PRESSE MED.; ISSN 0301-1518; FRA; DA. 1981; VOL. 10; NO 3; PP. 175; BIBL. 4 REF.Article

Intrazelluläre Wirkung von Josamycin = Action intracellulaire de la josamycine = Intracellular action of JosamycinWILDFEUER, A; LAUFEN, H; GALLE, J et al.Arzneimittel-Forschung. 1986, Vol 36, Num 1, pp 127-131, issn 0004-4172Article

JOSAMYCINE ET PATHOLOGIE INFECTIEUSE EN PEDIATRIE: ETUDE CLINIQUEGRENIER B.1981; ANN. PEDIATR. (PARIS); ISSN 0066-2097; FRA; DA. 1981; VOL. 28; NO 6; PP. 443-446; ABS. ENGArticle

A case-control teratological study of spiramycin, roxithromycin, oleandomycin and josamycinCZEIZEL, A. E; ROCKENBAUER, M; OLSEN, J et al.Acta obstetricia et gynecologica Scandinavica. 2000, Vol 79, Num 3, pp 234-237, issn 0001-6349Article

ETUDE DE L'EFFICACITE ET DE LA TOLERANCE DE LA JOSAMYCINE DANS LE TRAITEMENT DES INFECTIONS BACTERIENNES BRONCHO-PULMONAIRESGERMOUTY J.1980; REV. MED. LIMOGES; ISSN 0375-1139; FRA; DA. 1980; VOL. 11; NO 4; PP. 309-314; BIBL. 5 REF.Article

LA JOSAMYCINE EN PATHOLOGIE PEDIATRIQUEBATTIN J; AUZERIE J.1980; BORDEAUX MED.; ISSN 0021-7867; FRA; DA. 1980; VOL. 13; NO 26; PP. 1489-1490Article

IN VITRO ACTIVITY OF JOSAMYCIN AGAINST AEROBIC GRAM-POSITIVE COCCI AND ANAEROBESWESTERMAN EL; WILLIAMS TW JR; MORELAND N et al.1976; ANTIMICROB. AGENTS CHEMOTHERAPY; U.S.A.; DA. 1976; VOL. 9; NO 6; PP. 988-993; BIBL. 8 REF.Article

Tacrolimus + Josamycine : Surdosage en tacrolimus = Tacrolimus + josamycine : overdosing of tacrolimusLa Revue Prescrire. 2005, Vol 25, Num 265, issn 0247-7750, p. 670Article

Modification of phagocytosis and cytokine production in peritoneal and splenic murine cells by erythromycin A, azithromycin and josamycinORTEGA, Elena; ESCOBAR, M. Antonia; GAFORIO, José Juan et al.Journal of antimicrobial chemotherapy (Print). 2004, Vol 53, Num 2, pp 367-370, issn 0305-7453, 4 p.Article

Emergence of group A streptococcus strains with different mechanisms of macrolide resistanceBINGEN, Edouard; LECLERCQ, Roland; FITOUSSI, Frédéric et al.Antimicrobial agents and chemotherapy. 2002, Vol 46, Num 5, pp 1199-1203, issn 0066-4804Article

Modulatory effect of macrolide antibiotics on the Th1- and Th2-type cytokine productionMORIKAWA, K; ZHANG, J; NONAKA, M et al.International journal of antimicrobial agents. 2002, Vol 19, Num 1, pp 53-59, issn 0924-8579Article

In-vitro antimicrobial activity of HMR 3004 (RU 64004) against erythromycin A-sensitive and -resistant Corynebacterium spp. isolated from clinical specimensSORIANO, F; FERNANDEZ-ROBLAS, R; CALVO, R et al.Journal of antimicrobial chemotherapy (Print). 1998, Vol 42, Num 5, pp 647-649, issn 0305-7453Article

Antimicrobial activity of josamycin against erythromycin-resistant Staphylococci as compared to Roxythromycin and ClarithromycinGUGGENBICHLER, J. P; GEORGOPOULOS, A; SCHARRER, P et al.Infection. 1993, Vol 21, Num 4, pp 259-261, issn 0300-8126Article

Colite pseudo membraneuse associée à un traitement par josamycine = Pseudomembranous colitis associated with josamycinCARLHANT, D; MAURY, M. O; BRESSOLETTE, L et al.Thérapie (Paris). 1987, Vol 42, Num 1, issn 0040-5957, 65Article

Théophylline et antibiotiques: absence d'interaction avec la josamycine = Theophylline and antibiotics: absence of interaction between theophylline and josamycineRUFF, F; PROSPER, M; PUJET, J. C et al.Thérapie (Paris). 1984, Vol 39, Num 1, pp 1-6, issn 0040-5957Article